$28.53
+0.13
(+0.46%)▲
0.75%
Downside
Day's Volatility :1.07%
Upside
0.31%
23.17%
Downside
52 Weeks Volatility :29.63%
Upside
8.41%
Period | Healthstream Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | -0.73% | 3.8% | 0.0% |
6 Months | 16.07% | 10.8% | 0.0% |
1 Year | 27.48% | 18.2% | 0.0% |
3 Years | 0.25% | 22.6% | -21.1% |
Market Capitalization | 867.5M |
Book Value | $11.48 |
Dividend Share | 0.106 |
Dividend Yield | 0.39% |
Earnings Per Share (EPS) | 0.59 |
PE Ratio | 48.36 |
PEG Ratio | 3.82 |
Wall Street Target Price | 32.0 |
Profit Margin | 6.26% |
Operating Margin TTM | 6.16% |
Return On Assets TTM | 2.42% |
Return On Equity TTM | 5.18% |
Revenue TTM | 285.2M |
Revenue Per Share TTM | 9.37 |
Quarterly Revenue Growth YOY | 3.4000000000000004% |
Gross Profit TTM | 175.7M |
EBITDA | 38.9M |
Diluted Eps TTM | 0.59 |
Quarterly Earnings Growth YOY | 0.06 |
EPS Estimate Current Year | 0.57 |
EPS Estimate Next Year | 0.64 |
EPS Estimate Current Quarter | 0.12 |
EPS Estimate Next Quarter | 0.12 |
What analysts predicted
Upside of 12.16%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 231.6M | ↓ 6.48% |
Net Income | 32.2M | ↑ 222.04% |
Net Profit Margin | 13.91% | ↑ 9.87% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 254.1M | ↑ 9.71% |
Net Income | 15.8M | ↓ 51.05% |
Net Profit Margin | 6.21% | ↓ 7.7% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 244.8M | ↓ 3.65% |
Net Income | 14.1M | ↓ 10.65% |
Net Profit Margin | 5.76% | ↓ 0.45% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 256.7M | ↑ 4.85% |
Net Income | 5.8M | ↓ 58.52% |
Net Profit Margin | 2.28% | ↓ 3.48% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 266.8M | ↑ 3.94% |
Net Income | 12.1M | ↑ 106.86% |
Net Profit Margin | 4.53% | ↑ 2.25% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 279.1M | ↑ 4.59% |
Net Income | 15.2M | ↑ 25.82% |
Net Profit Margin | 5.45% | ↑ 0.92% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 68.9M | ↑ 0.6% |
Net Income | 2.6M | ↑ 7.1% |
Net Profit Margin | 3.8% | ↑ 0.23% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 69.2M | ↑ 0.37% |
Net Income | 4.1M | ↑ 57.57% |
Net Profit Margin | 5.97% | ↑ 2.17% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 70.3M | ↑ 1.65% |
Net Income | 3.9M | ↓ 6.44% |
Net Profit Margin | 5.5% | ↓ 0.47% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 70.6M | ↑ 0.34% |
Net Income | 4.6M | ↑ 18.7% |
Net Profit Margin | 6.5% | ↑ 1.0% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 72.8M | ↑ 3.09% |
Net Income | 5.2M | ↑ 13.88% |
Net Profit Margin | 7.18% | ↑ 0.68% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 71.6M | ↓ 1.65% |
Net Income | 4.2M | ↓ 20.26% |
Net Profit Margin | 5.82% | ↓ 1.36% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 440.2M | ↑ 7.08% |
Total Liabilities | 121.2M | ↑ 9.3% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 489.5M | ↑ 11.22% |
Total Liabilities | 151.4M | ↑ 24.88% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 500.3M | ↑ 2.2% |
Total Liabilities | 166.3M | ↑ 9.83% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 486.8M | ↓ 2.71% |
Total Liabilities | 147.7M | ↓ 11.14% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 497.7M | ↑ 2.26% |
Total Liabilities | 163.7M | ↑ 10.79% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 499.9M | ↑ 0.44% |
Total Liabilities | 159.2M | ↓ 2.74% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 503.2M | ↑ 1.09% |
Total Liabilities | 167.1M | ↑ 2.1% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 493.5M | ↓ 1.92% |
Total Liabilities | 152.9M | ↓ 8.54% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 498.1M | ↑ 0.93% |
Total Liabilities | 155.8M | ↑ 1.93% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 499.9M | ↑ 0.38% |
Total Liabilities | 159.2M | ↑ 2.17% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 511.6M | ↑ 2.33% |
Total Liabilities | 166.8M | ↑ 4.75% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 499.6M | ↓ 2.36% |
Total Liabilities | 150.3M | ↓ 9.84% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 43.2M | ↓ 7.42% |
Investing Cash Flow | 36.6M | ↓ 415.73% |
Financing Cash Flow | -30.3M | ↓ 3025200.0% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 65.7M | ↑ 51.82% |
Investing Cash Flow | -67.5M | ↓ 284.7% |
Financing Cash Flow | -916.0K | ↓ 96.97% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 35.9M | ↓ 45.36% |
Investing Cash Flow | -110.4M | ↑ 63.51% |
Financing Cash Flow | -20.5M | ↑ 2137.34% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 42.4M | ↑ 18.15% |
Investing Cash Flow | -25.7M | ↓ 76.7% |
Financing Cash Flow | -6.2M | ↓ 69.7% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 51.2M | ↑ 20.77% |
Investing Cash Flow | -28.4M | ↑ 10.36% |
Financing Cash Flow | -23.7M | ↑ 281.74% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 20.5M | ↑ 153.34% |
Investing Cash Flow | -16.9M | ↑ 63.25% |
Financing Cash Flow | -791.0K | ↑ 1582.98% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 4.9M | ↓ 75.91% |
Investing Cash Flow | -26.4M | ↑ 55.94% |
Financing Cash Flow | -1.5M | ↑ 94.69% |
Sell
Neutral
Buy
Healthstream Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Healthstream Inc | -0.87% | 16.07% | 27.48% | 0.25% | 10.07% |
Solventum Corp | -2.66% | 10.46% | -1.39% | -1.39% | -1.39% |
Doximity, Inc. | 10.15% | 70.38% | 100.51% | -44.37% | -18.28% |
Veeva Systems Inc. | -3.04% | 4.81% | -2.22% | -29.32% | 37.91% |
Ge Healthcare Technologies Inc. | 4.74% | 5.69% | 35.62% | 50.49% | 50.49% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Healthstream Inc | 48.36 | 48.36 | 3.82 | 0.57 | 0.05 | 0.02 | 0.0 | 11.48 |
Solventum Corp | NA | NA | NA | 6.26 | 0.17 | 0.08 | NA | NA |
Doximity, Inc. | 54.14 | 54.14 | 2.42 | 0.9 | 0.17 | 0.11 | NA | 4.92 |
Veeva Systems Inc. | 56.5 | 56.5 | 1.21 | 4.76 | 0.13 | 0.06 | NA | 32.04 |
Ge Healthcare Technologies Inc. | 26.08 | 26.08 | 2.37 | 4.25 | 0.21 | 0.06 | 0.0 | 17.08 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Healthstream Inc | Buy | $867.5M | 10.07% | 48.36 | 6.26% |
Solventum Corp | Hold | $10.8B | -1.39% | NA | 15.73% |
Doximity, Inc. | Hold | $8.0B | -18.28% | 54.14 | 32.53% |
Veeva Systems Inc. | Buy | $34.2B | 37.91% | 56.5 | 23.91% |
Ge Healthcare Technologies Inc. | Buy | $41.2B | 50.49% | 26.08 | 8.1% |
Insights on Healthstream Inc
Revenue is down for the last 2 quarters, 72.76M → 71.55M (in $), with an average decrease of 1.7% per quarter
Netprofit is down for the last 2 quarters, 5.22M → 4.16M (in $), with an average decrease of 20.3% per quarter
In the last 1 year, Doximity, Inc. has given 100.5% return, outperforming this stock by 73.0%
BlackRock Inc
Vanguard Group Inc
Dimensional Fund Advisors, Inc.
State Street Corp
Punch & Associates Inv Mgmt Inc
Renaissance Technologies Corp
thousands of healthcare providers, including half of u.s. hospitals, have chosen healthstream (nasdaq: hstm) as their partner for improving clinical and business outcomes. in this new era of healthcare reform, meaningful use, and value-based purchasing, hundreds of leading organizations each year are switching to healthstream to elevate the role of learning and development in addressing these challenges. our vision healthstream’s vision is to improve the quality of healthcare by assessing and developing the people who deliver care.
Organization | Healthstream Inc |
Employees | 1079 |
CEO | Mr. Robert A. Frist Jr. |
Industry | Technology Services |
Metal Sky Star Acquisition Corp
$28.53
+0.46%
Stone Ridge 2054 Longevity Income Etf
$28.53
+0.46%
International Money Express
$28.53
+0.46%
Nabors Energy Transition Corp Ii
$28.53
+0.46%
Western Asset High Income Fund Ii Inc
$28.53
+0.46%
Dimensional Us Core Equity 1 Etf
$28.53
+0.46%
Natuzzi Spa
$28.53
+0.46%
Swan Hedged Equity Us Lg Cap
$28.53
+0.46%
Jpmorgan Activebuilders Emer
$28.53
+0.46%